+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
COHANCE

Cohance Lifesciences Share Price

₹476.05 -3.2 (-0.67%)
45.33% Fall from 52W High

28 Oct, 2026 3:58 PM (IST)

Cohance Lifesciences live price: ₹476.05. It opened at ₹484 vs previous close ₹479; intraday high/low: ₹487/₹472. The 50 & 200 DMA stand at ₹451.50/₹484.50.

Cohance Lifesciences Performance

  • Today's Low
  • ₹472
  • Today's High
  • ₹487
  • 52 Week Low
  • ₹267
  • 52 Week High
  • ₹871
  • Open Price₹484
  • Previous Close₹479
  • Volume654,285
  • 50 DMA₹451.50
  • 100 DMA₹447.10
  • 200 DMA₹484.50

Cohance Lifesciences Chart

Investment Returns

  • Over 1 Month + 3.66%
  • Over 3 Month + 11.23%
  • Over 6 Month + 10.17%
  • Over 1 Year -44.02%

Smart Investing Starts Here Start SIP with Cohance Lifesciences for Steady Growth!

Invest Now

Cohance Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 171.5
  • PEG Ratio
  • -2.9
  • Market Cap Cr
  • 18,214
  • P/B Ratio
  • 4.7
  • Average True Range
  • 16.6
  • EPS
  • 2.8
  • Dividend Yield
  • 0
  • MACD Signal
  • 5.3
  • RSI
  • 60.25
  • MFI
  • 70.53

Latest Stock News Updates

Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Results Conference Call

Cohance Lifesciences Ltd - 543064 - Board Meeting Intimation for Considering The Unaudited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter And Half Year Ended 30 September 2026

Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company, for the Quarter and Half year ended 30 September 2026

Cohance Lifesciences Ltd - 543064 - General Updates

General updates

Cohance Lifesciences Financials

Cohance Lifesciences Technicals

EMA & SMA

Current Price
₹476.05
-3.2 (-0.67%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹457.50
  • 50 Day
  • ₹451.50
  • 100 Day
  • ₹447.10
  • 200 Day
  • ₹484.50

Resistance and Support

478.38 Pivot Speed
  • R3 500.80
  • R2 494.10
  • R1 485.10
  • S1 469.40
  • S2 462.70
  • S3 453.70

Cohance Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-06 Quarterly Results
2026-08-05 Quarterly Results
2026-05-12 Audited Results
2026-02-12 Quarterly Results
2025-11-12 Quarterly Results
Date Purpose Remarks
2022-09-12 INTERIM Rs.1.00 per share(100%)Interim Dividend
2022-09-12 SPECIAL Rs.5.00 per share(500%)Special Dividend
2022-05-17 INTERIM Re.1.00 per shaer (100%) Second Interim Dividend
2022-05-17 SPECIAL Rs.1.00 per share(100%)Special Dividend
2022-02-16 INTERIM Rs.1.00 per share(100%)Interim Dividend
View Cohance Lifesciences Dividend History Arrow

Cohance Lifesciences Shareholding Pattern

57.48%
16.93%
15.95%
7.71%
1.93%

About Cohance Lifesciences

Cohance Lifesciences engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. View More
  • NSE Symbol
  • COHANCE
  • BSE Symbol
  • 543064
  • ISIN
  • INE03QK01018

Similar Stocks to Cohance Lifesciences

Cohance Lifesciences FAQs

Cohance Lifesciences share price is ₹476 As on 29 October, 2026 | 02:06

The Market Cap of Cohance Lifesciences is ₹18213.5 Cr As on 29 October, 2026 | 02:06

The P/E ratio of Cohance Lifesciences is 171.5 As on 29 October, 2026 | 02:06

The PB ratio of Cohance Lifesciences is 4.7 As on 29 October, 2026 | 02:06

The 52 week High & Low of Cohance Lifesciences is ₹870.8/₹266.7 respectively As on 29 October, 2026 | 02:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23